Predictive diagnostics in colorectal cancer: impact of genetic polymorphisms on individual outcomes and treatment with fluoropyrimidine-based chemotherapy

Por Schwarzenbach, Heidi
Publicado em 2010

Circulating nucleic acids as biomarkers in breast cancer

Por Schwarzenbach, Heidi
Publicado em 2013

Biological and Clinical Relevance of H19 in Colorectal Cancer Patients

Por Schwarzenbach, Heidi
Publicado no EBioMedicine (2016)

Circulating DNA as biomarker in breast cancer

Por Schwarzenbach, Heidi, Pantel, Klaus
Publicado no Breast Cancer Res (2015)

Promoter- and cell-specific epigenetic regulation of CD44, Cyclin D2, GLIPR1 and PTEN by Methyl-CpG binding proteins and histone modifications

Por Müller, Imke, Wischnewski, Frank, Pantel, Klaus, Schwarzenbach, Heidi
Publicado em 2010

Which is the accurate data normalization strategy for microRNA quantification?

Por Schwarzenbach, Heidi, da Silva, Andreia Machado, Calin, George, Pantel, Klaus
Publicado no Clin Chem (2015)

Circulating Mitochondrial DNA as Biomarker Linking Environmental Chemical Exposure to Early Preclinical Lesions Elevation of mtDNA in Human Serum after Exposure to Carcinogenic Hal...

Por Budnik, Lygia T., Kloth, Stefan, Baur, Xaver, Preisser, Alexandra M., Schwarzenbach, Heidi
Publicado em 2013

A critical evaluation of loss of heterozygosity detected in tumor tissues, blood serum and bone marrow plasma from patients with breast cancer

Por Schwarzenbach, Heidi, Müller, Volkmar, Beeger, Cord, Gottberg, Miriam, Stahmann, Nicole, Pantel, Klaus
Publicado em 2007

Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer

Por Roth, Carina, Rack, Brigitte, Müller, Volkmar, Janni, Wolfgang, Pantel, Klaus, Schwarzenbach, Heidi
Publicado em 2010

Circulating microRNAs: promising breast cancer biomarkers - authors' response

Por Roth, Carina, Rack, Brigitte, Müller, Volkmar, Janni, Wolfgang, Pantel, Klaus, Schwarzenbach, Heidi
Publicado em 2011

Aberrant plasma levels of circulating miR-16, miR-107, miR-130a and miR-146a are associated with lymph node metastasis and receptor status of breast cancer patients

Por Stückrath, Isabel, Rack, Brigitte, Janni, Wolfgang, Jäger, Bernadette, Pantel, Klaus, Schwarzenbach, Heidi
Publicado no Oncotarget (2015)

Low Levels of Cell-Free Circulating miR-361-3p and miR-625* as Blood-Based Markers for Discriminating Malignant from Benign Lung Tumors

Por Roth, Carina, Stückrath, Isabel, Pantel, Klaus, Izbicki, Jakob R., Tachezy, Michael, Schwarzenbach, Heidi
Publicado em 2012

Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer

Por Meng, Xiaodan, Müller, Volkmar, Milde-Langosch, Karin, Trillsch, Fabian, Pantel, Klaus, Schwarzenbach, Heidi
Publicado no Oncotarget (2016)

LOH at 6q and 10q in fractionated circulating DNA of ovarian cancer patients is predictive for tumor cell spread and overall survival

Por Kuhlmann, Jan Dominik, Schwarzenbach, Heidi, Wimberger, Pauline, Poetsch, Micaela, Kimmig, Rainer, Kasimir-Bauer, Sabine
Publicado em 2012

Differential regulation of MAGE-A1 promoter activity by BORIS and Sp1, both interacting with the TATA binding protein

Por Schwarzenbach, Heidi, Eichelser, Corinna, Steinbach, Bettina, Tadewaldt, Josefine, Pantel, Klaus, Lobanenkov, Victor, Loukinov, Dmitri
Publicado no BMC Cancer (2014)

Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancer

Por Schwarzenbach, Heidi, Pantel, Klaus, Kemper, Birthe, Beeger, Cord, Otterbach, Friedrich, Kimmig, Rainer, Kasimir-Bauer, Sabine
Publicado em 2009

Apoptosis-related deregulation of proteolytic activities and high serum levels of circulating nucleosomes and DNA in blood correlate with breast cancer progression

Por Roth, Carina, Pantel, Klaus, Müller, Volkmar, Rack, Brigitte, Kasimir-Bauer, Sabine, Janni, Wolfgang, Schwarzenbach, Heidi
Publicado em 2011

Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients

Por Eichelser, Corinna, Stückrath, Isabel, Müller, Volkmar, Milde-Langosch, Karin, Wikman, Harriet, Pantel, Klaus, Schwarzenbach, Heidi
Publicado no Oncotarget (2014)

Tumor-Induced Osteoclast miRNA Changes as Regulators and Biomarkers of Osteolytic Bone Metastasis

Por Ell, Brian, Mercatali, Laura, Ibrahim, Toni, Campbell, Neil, Schwarzenbach, Heidi, Pantel, Klaus, Amadori, Dino, Kang, Yibin
Publicado em 2013

Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients

Por Meng, Xiaodan, Joosse, Simon A, Müller, Volkmar, Trillsch, Fabian, Milde-Langosch, Karin, Mahner, Sven, Geffken, Maria, Pantel, Klaus, Schwarzenbach, Heidi
Publicado no Br J Cancer (2015)